Dr. Reddy's Laboratories RDY Stock
Dr. Reddy's Laboratories Price Chart
Dr. Reddy's Laboratories RDY Financial and Trading Overview
Dr. Reddy's Laboratories stock price | 14.56 USD |
Previous Close | 57.71 USD |
Open | 58.53 USD |
Bid | 0 USD x 900 |
Ask | 0 USD x 1400 |
Day's Range | 58.49 - 59.52 USD |
52 Week Range | 49.8 - 61.4 USD |
Volume | 215.14K USD |
Avg. Volume | 250.08K USD |
Market Cap | 9.87B USD |
Beta (5Y Monthly) | 0.230136 |
PE Ratio (TTM) | 18.05775 |
EPS (TTM) | 0.8 USD |
Forward Dividend & Yield | 0.49 (0.85%) |
Ex-Dividend Date | July 7, 2023 |
1y Target Est | 65.03 USD |
RDY Valuation Measures
Enterprise Value | 9.15B USD |
Trailing P/E | 18.05775 |
Forward P/E | 17.576923 |
PEG Ratio (5 yr expected) | 43.54 |
Price/Sales (ttm) | 0.04013888 |
Price/Book (mrq) | 0.25584713 |
Enterprise Value/Revenue | 0.037 |
Enterprise Value/EBITDA | 0.139 |
Trading Information
Dr. Reddy's Laboratories Stock Price History
Beta (5Y Monthly) | 0.230136 |
52-Week Change | 11.65% |
S&P500 52-Week Change | 20.43% |
52 Week High | 61.4 USD |
52 Week Low | 49.8 USD |
50-Day Moving Average | 57.8 USD |
200-Day Moving Average | 54.74 USD |
RDY Share Statistics
Avg. Volume (3 month) | 250.08K USD |
Avg. Daily Volume (10-Days) | 192.21K USD |
Shares Outstanding | 166.12M |
Float | 710.14M |
Short Ratio | 6.66 |
% Held by Insiders | 0% |
% Held by Institutions | 10.47% |
Shares Short | 1.89M |
Short % of Float | N/A |
Short % of Shares Outstanding | 1.14% |
Dividends & Splits
Trailing Annual Dividend Rate | 40 |
Trailing Annual Dividend Yield | 69.31% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2023 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | March 31, 2024 |
Profitability
Profit Margin | 18.32% |
Operating Margin (ttm) | 21.63% |
Gross Margin | 56.67% |
EBITDA Margin | 26.77% |
Management Effectiveness
Return on Assets (ttm) | 10.81% |
Return on Equity (ttm) | 21.38% |
Income Statement
Revenue (ttm) | 245.88B USD |
Revenue Per Share (ttm) | 247.31 USD |
Quarterly Revenue Growth (yoy) | 15.80% |
Gross Profit (ttm) | N/A |
EBITDA | 65.83B USD |
Net Income Avi to Common (ttm) | 45.07B USD |
Diluted EPS (ttm) | 3.29 |
Quarterly Earnings Growth (yoy) | 996.19% |
Balance Sheet
Total Cash (mrq) | 61.8B USD |
Total Cash Per Share (mrq) | 62.12 USD |
Total Debt (mrq) | 13.47B USD |
Total Debt/Equity (mrq) | 5.83 USD |
Current Ratio (mrq) | 2.411 |
Book Value Per Share (mrq) | 232.20898 |
Cash Flow Statement
Operating Cash Flow (ttm) | 58.87B USD |
Levered Free Cash Flow (ttm) | 26.61B USD |
Profile of Dr. Reddy's Laboratories
Country | United States |
State | N/A |
City | Hyderabad |
Address | 8-2-337, Road No. 3 |
ZIP | 500034 |
Phone | 91 40 4900 2900 |
Website | https://www.drreddys.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
Q&A For Dr. Reddy's Laboratories Stock
What is a current RDY stock price?
Dr. Reddy's Laboratories RDY stock price today per share is 14.56 USD.
How to purchase Dr. Reddy's Laboratories stock?
You can buy RDY shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Dr. Reddy's Laboratories?
The stock symbol or ticker of Dr. Reddy's Laboratories is RDY.
Which industry does the Dr. Reddy's Laboratories company belong to?
The Dr. Reddy's Laboratories industry is Drug Manufacturers-Specialty & Generic.
How many shares does Dr. Reddy's Laboratories have in circulation?
The max supply of Dr. Reddy's Laboratories shares is 832.3M.
What is Dr. Reddy's Laboratories Price to Earnings Ratio (PE Ratio)?
Dr. Reddy's Laboratories PE Ratio is 18.20000000 now.
What was Dr. Reddy's Laboratories earnings per share over the trailing 12 months (TTM)?
Dr. Reddy's Laboratories EPS is 0.8 USD over the trailing 12 months.
Which sector does the Dr. Reddy's Laboratories company belong to?
The Dr. Reddy's Laboratories sector is Healthcare.
Dr. Reddy's Laboratories RDY included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NYSE Arca Pharmaceutical Index DRG | 899.04 USD — |
-1.06
|
— — | — — | — — | — - | — — |
NYSE Composite Index NYA | 19678.94 USD — |
-0.76
|
— — | — — | — — | — - | — — |
ISE BICK Index BIQ | 233.14 USD — |
<0.01
|
— — | 233.08 USD — | 234.49 USD — | — - | — — |
- {{ link.label }} {{link}}